Zusammenfassung
Die akute Überempfindlichkeit ist das Kennzeichen jeder allergischen Reaktion. Sie kommt zustande, wenn der Kontakt mit einem bestimmten Antigen die Bildung von Antikörpern ausgelöst hat, die sich an die Fc-Rezeptoren von Mastzellen oder basophilen Leukozyten binden. Erneuter Kontakt mit demselben Antigen führt dann zum „bridging“, d.h. zu einer Vernetzung benachbarter Antikörpermoleküle auf der Zelloberfläche über ihre antigenbindenden Anteile. Durch die Antigen-An-tikörperreaktion entsteht ein Signal am Fc-Rezeptor, das über eine Kette biochemischer Ereignisse, über die zu reden sein wird, zur Freisetzung sog. Mediatoren aus den Granula der Mastzellen und der basophilen Leukozyten führt.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Allgemeine Literatur
Goldberg ME (ed) (1981): Pharmacological and Biochemical Properties of Drug Substances, Volumes. Published by: American Pharmaceutical Association Academy of Pharmaceutical Sciences
Morley J (1982): Bronchial Hyperreactivity. Academic Press, London, New York, Paris, San Diego, San Francisco, São Paulo, Sydney, Tokyo, Toronto
Oppenheim JJ, Rosenstreich DL, Potter M (eds) (1981): Cellular functions in immunity and inflammation. Elsevier/North Holland, New York, Amsterdam
Parker W (1982): Allergic reactions in man. Pharmacological Reviews, Vol 34, No 1, 85–104
Wilson JD (1982): Asthma and Allergic Diseases: A Clinician’s Guide to Diagnosis and Management. ADIS Health Science Press, Sydney, Auckland, Bristol, Boston, Hong Kong, Tokyo
Zitierte Literatur
Alm PE (1984): Modulation of mast cell cAMP levels. Int Archs Allergy Appl Immun 75, 375–378
Askenase PW, Schwartz A, Siegel JN, Gershon RK (1981): Role of histamine in the regulation of cell-mediated immunity. Int Archs Allergy Appl Immun 66 (Suppl 1), 225–233
Balch CM, Dougherty PA, Cloud GA, Tilden AB (1983): Prostaglandin E2-mediated suppression of cellular immunity in colon cancer patients. Surgery, Vol 92, No 1, 72–77
Beaven MA, Moore JP, Smith GA, Hesketh TR, Metcalfe JC (1983): The calcium signal and phosphatidylinositol breakdown in 2H3. The Journal of Biological Chemistry, Vol 259, No 11, Issue of June 10, 7137–7142
Bernstein IL (1981): Cromolyn sodium in the treatment of asthma: changing concepts. The Journal of Allergy and Clinical Immunology, Vol 68, No 4, 247–253
Berridge J, Irvine RF (1984): Inositol trisphophate, a novel second messenger in cellular signal transduction. Nature, Vol 312, 22 November 1984, 315–321
Bonney RJ, Humes JL (1984): Physiological and pharmacological regulation of prostaglandin and leukotriene production by macrophages. Journal of Leukocyte Biology 35, 1–10
Bunting S, Moncada S, Vane JR (1983): The prostacyclin-thromboxane A2 balance: pathophysiological and therapeutic implications. British Medical Bulletin, Vol 39, No 3, 271–276
Craps LP, Ney UM (1984): Ketotifen: Current views on its mechanism of action and their therapeutic implications. Respiration 45, 411–421
Craps LP (1985): Immunologic and therapeutic aspects of ketotifen. In press in: J Allerg Clin Immunol Mosby Co
Craps LP (1985): Ketotifen. To be published in „Highlights in Asthmology“ Springer Heidelberg, Berlin, New York
Craps LP, Greenwood C, Ney UM (1985): Ketotifen and asthma. In: Bronchial-Asthma-Mech- anisms and Therapeutics, 2nd edition (Weiss EB, Segal MS, Stein M, eds). Little, Brown and Co, Boston, Mass, 734–740
Davies RJ, Moodley I (1982): Antiallergic compounds. Pharmac Ther Vol 17, 279–297
Deguchi H, Suemura M, Ishizaka A, Ozaki Y, Kishimoto S, Yamamura Y, Kishimoto T (1983): Immunoglobulin E class specific suppressor T cells and factors in humans. J Immunol 131 (6), 2751–2756
Diamant B (1982): Histamine secretion: Research in retrospect. Agents and Actions, Vol 12, 1/2, 5–11
Eiser NM (1982): Histamine antagonists and asthma. Pharmac Ther Vol 17, 239–250
Fernandez JM, Neher E, Gomperts BD (1984): Capacitance measurements reveal stepwise fusion events in degranulating mast cells. Nature, Vol 312, 29 November 1984, 453–454
Gemsa D, Deimann W, Bärlin E, Seitz M, Leser H-G (1982): Die Rolle von Prostaglandinen aus Makrophagen bei Regulation und Suppression der Immunantwort. Allergologie, Jahrgang 5, Nr 4, 142–150
Goetzl EJ, Payan DG, Goldman DW (1984): Immunopathogenetic roles of leukotrienes in human diseases. Journal of Clinical Immunology, Vol 4, No 2, 79–84
Gomperts BD (1983): Involvement of guanine nucleotide-binding protein in the gating of Ca2+ by receptors. Nature, Vol 306, 3 November 1983, 64–66
Goodwin JS, Ceuppens J (1983): Regulation of the immune response by prostaglandins. Journal of Clinical Immunology, Vol 3, No 4, 295–315
Hanson JM, Rumjanek VM, Morley J (1982): Mediators of cellular immune reactions. Pharmac Ther 17, 165–198
Hassner A, Saxon A (1984): Isotype specific human suppressor T cells for immunoglobulin E synthesis activated by immunoglobulin E antiimmunoglobuline E immune complexes. J Immunol 132 (6), 2844–2849
Huff TF, Yodoi J, Uede T, Ishizaka K (1984): Presence of an antigenic determinant common to rat IgE-potentiating factor, IgE-suppressive factor, and Fc receptors on T and B lymphocytes. The Journal of Immunology, Vol 132, No 1, 406–412
Ishizuka Y, Imai A, Nakashima S, Nozawa Y (1983): Evidence for de novo synthesis of phosphatidylinositol coupled with histamine release in activated rat mast cells. Biochemical and Biophysical Research Communications, 581–587
Iwata M, Akasaki M, Ishizaka K (1984): Modulation of the biologic activities of IgE-binding factor. VI. The activation of phospholipase by glycosylation enhancing factor. The Journal of Immunology, Vol 133, No 3, 1505–1512
Iwata M, Huff TF, Ishizaka K (1984): Modulation of the biologic activities of IgE-binding factor. V. The role of glycosylation-enhancing factor and glycosylation-inhibiting factor in determining the nature of IgE-binding factors. The Journal of Immunology, Vol 132, No 3, 1286–1293
James MP, Kennedy AR, Eady RAJ (1982): A microscopic study of inflammatory reactions in human skin induced by histamine and compound 48/80. Journ Investig Dermatol, Vol 78, No 5, 406–413
Jardieu P, Uede T, Ishizaka K (1984): IgE-binding factors from mouse T lymphocytes. III. Role of antigen-specific suppressor T-cells in the formation of IgE-suppressive factor. The Journal of Immunology, Vol 133, No 6, 3266–3273
Katz DH (1984): Regulation of the IgE system: experimental and clinical aspects. Allergy 39, 81–106
Katz DH, Chen S-S, Liu F-T, Bogowitz CA, Katz LR (1984): Biologically active molecules regulating the immunoglobulin E antibody system, biochemical and biological comparisons of suppressive factor of allergy and enhancing factor of allergy. J Mol Cell Imunol 1 (3), 157–166
Kraemer MJ, Ochs HD, Furukawa CT, Wedgwood RJ (1982): In-vitro studies of the hyperimmunoglobulin E-disorders: suppression of spontaneous immunoglobulin E synthesis by allogeneic suppressor T lymphocytes. Clin Immunol Immunopathol 25 (2), 157–164
Lagunoff D, Martin TW, Read G (1983): Agents that release histamine from mast cells. Ann Rev Pharmacol Toxicol 23, 331–351
Leung DY, Brozek C, Frankel R, Geha RS (1984): IgE-specific suppressor factors in normal human serum. Clin Immunol Immunopathol (United States) 32 (3), 339–350
Leung DYM, Geha RS (1984): Regulation of IgE synthesis in man. Clinical Immunology Reviews, 3 (1), 1–24
Lim LK, Hunt NH, Eichner RD, Weidemann MJ (1983): Cyclic AMP and the regulation of prostaglandin production by macrophages. Biochemical and Biophysical Research Communications, 248–254
Mazurek N, Schindler H, Schürholz Th, Pecht I (1984): The cromolyn binding protein constitutes the Ca2+ channel of basophils opening upon immunological stimulus. Proc Natl Acad Sci USA, Vol 81, 6841–6845
Nishizuka Y (1984): The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature, Vol 308, 19 April 1984, 693–698
Nom S, Stahlskov P, Kock Chr, Andersen P, Pedersen M, Tønnesen P, Pedersen PS, Møller NE, Hertz J, Høiby N (1982): Intrinsic asthma and bacterial histamine release. Agents and Actions, Vol 12, 1/2, 101–102
Pelikan Z (1982): The effects of disodium chromoglycate and beclomethasone dipropionate on the late nasal mucosa response to allergen challenge. Annals of Allergy 49 (4), 200–212
Piper PJ (1983): Pharmacology of leukotrienes. British Medical Bulletin, Vol 39, No 3, 255–259
Resta O, Barbaro MPF, Camimeo N (1982): A comparison of sodium chromoglycate nasal solution and powder in the treatment of allergic rhinitis. The British Journal of Clinical Practice, Volume 36, No 3, March 1982
Rocklin RE (1983): Clinical and immunologic aspects of allergen-specific immunotherapy in patients with seasonal allergic rhinitis and/or allergic asthma. The Journal of Allergy and Clinical Immunology, Vol 72, No 4, October 1983
Rocklin RE, Beer DJ (1983): Histamine and immune modulation. Advances in Internal Medicine, Vol 28, 225–251. In: 1983, Year Book Medical Publishers, Inc
Sagi-Eisenberg R, Lieman H, Pecht I (1985): Protein kinase C regulation of the receptor-coupled calcium signal in histamine-secreting rat basophilic leukaemia cells. Nature, Vol 313, 59–60
Sampson HA (1983): Prospects for control of the IgE antibody response. Pediatric Clinics of North America, Vol 30, No 5, 773–785
Schild HO (1981): The multiple facets of histamine research. Agents and Actions, Vol 11, 1/2, 12–19
Schnitzler S, Eckert R, Volk D, Grunow R (1982): Histamin und Immunreaktionen. Allergie u Immunol 28, 219–235
Stokes TC, Morley J (1981): Prospects for an oral intake. Br J Dis Chest (1981) 75, 1–14
Tomilets VA (1982): Role of cyclic nucleotides in the immunomodulating action of histamine in mice. Bullet Experim Biol and Medicine, Vol 93, No 6, 79–80
Uede T, Huff TF, Ishizaka K (1984): Suppression of IgE synthesis in mouse plasma cells and B cells by rat IgE-suppressive factor. The Journal of Immunology, Vol 133, No 2, 803–808
Uede T, Ishizaka K (1984): IgE-binding factors from mouse T lymphocytes. II. Strain differences in the nature of IgE-binding factor. The Journal of Immunology, Vol 133, No 1, 359–367
Volpi M, Yassin R, Naecache PH, Sha’afi RI (1983): Chemotactic factor causes rapid decreases in phosphatidylinositol, 4,5-bisphosphate and phosphatidylinositol 4-monophosphate in rabbit neutrophils. Biochemical and Biophysical Research Communications, Vol 112, No 3, 957–964
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Drews, J. (1986). Substanzen mit antiallergischer Wirkung. In: Immunpharmakologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70502-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-70502-1_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-15456-3
Online ISBN: 978-3-642-70502-1
eBook Packages: Springer Book Archive